Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Rho Joins Avoca Quality Consortium | Contract Pharma
Breaking News

Rho Joins Avoca Quality Consortium

Gains access to AQC Knowledge Center with leading practices, guidelines, tools, and templates aimed at improving quality

Rho, a CRO, has become a member of The Avoca Quality Consortium (AQC), a collaborative effort focused on quality and compliance in the execution of clinical trials.
 
As a member, Rho has unlimited company-wide access to the AQC Knowledge Center, an online portal with more than 400 leading practices, guidelines, tools, and templates to help increase efficiency, improve quality, and mitigate risk in clinical trials. Other benefits include access to educational webinars, networking events, executive roundtables, leadership advisory boards and expert groups and invitations to exclusive events including the Fall Working Session and Annual Global Summit, which gathers life science leaders from around the world to connect and share best practices and ideas.
 
“Membership in this consortium reaffirms Rho’s commitment to quality and compliance in clinical trials,” said Brook White, executive director, corporate communications at Rho. “Aligning ourselves with groups like the Avoca Quality Consortium gives our researchers access to the best resources, which demonstrates to our customers that we can provide the highest quality work.” 
 
Rho joins more than 100 member companies in the Avoca Quality Consortium.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters